Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
PVSRIPO
United Therapeutics Europe Ltd
Invasive Breast Cancer
1 trial -
Palbociclib + Taselisib / Pictilisib
United Therapeutics Europe Ltd
Advanced Solid Tumours
1 trial -
Pembrolizumab
United Therapeutics Europe Ltd
Thoracic Tumours
1 trial -
Pembrolizumab
United Therapeutics Europe Ltd
Cervix Cancer
1 trial -
Physical Activity Educational Materials
United Therapeutics Europe Ltd
Physical Inactivity
1 trial -
Pitavastatin
United Therapeutics Europe Ltd
Acute Myeloid Leukemia
1 trial -
Placebo Intravaginal Ring A
United Therapeutics Europe Ltd
Safety
1 trial -
Placebo Vaginal Film with Square Corners
United Therapeutics Europe Ltd
Safety
1 trial -
Plasmodium falciparum Malaria Protein 010 (FMP010)
United Therapeutics Europe Ltd
Malaria
1 trial -
Plerixafor
United Therapeutics Europe Ltd
Pancreatic Adenocarcinoma Metastatic
1 trial -
Pramipexole
United Therapeutics Europe Ltd
Parkinson Disease
1 trial -
Protexia
United Therapeutics Europe Ltd
Intervention for Nerve Agent Exposure
1 trial -
Provision of extra (care coordination and management) services
United Therapeutics Europe Ltd
Hospitalization
1 trial -
Psilocybin
United Therapeutics Europe Ltd
Amyotrophic Lateral Sclerosis
1 trial -
Q-Griffithsin
United Therapeutics Europe Ltd
COVID-19 Prevention
1 trial -
Q-Griffithsin 3.0
United Therapeutics Europe Ltd
COVID-19 Prevention
1 trial -
Rehabilitation
United Therapeutics Europe Ltd
Stroke
1 trial -
SOM 230 / Pasireotide
United Therapeutics Europe Ltd
Atypical Ductal Breast Hyperplasia
1 trial -
Shigella sonnei 53G
United Therapeutics Europe Ltd
Healthy
1 trial -
Shigella sonnei 53G
United Therapeutics Europe Ltd
Shigellosis
2 trials -
Simvastatin
United Therapeutics Europe Ltd
Recurrent Acute Pancreatitis
1 trial -
TAF/EVG Vaginal Insert
United Therapeutics Europe Ltd
Hiv
1 trial -
TAF/EVG vaginal insert
United Therapeutics Europe Ltd
Safety Issues
1 trial -
Tepotinib
United Therapeutics Europe Ltd
Advanced Cancer
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources